Skip to content

A Novel Closed-loop Integrated System for the Maintenance of Haemodynamic Stability

A Novel Closed-loop Integrated System for the Maintenance of Haemodynamic Stability to Improve Perioperative Outcome During Spinal Anaesthesia for Caesarean Section

Status
Completed
Phases
Phase 2Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02277730
Acronym
DIVA
Enrollment
252
Registered
2014-10-29
Start date
2013-05-01
Completion date
2017-12-01
Last updated
2026-08-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypotension

Keywords

Hypotension

Brief summary

Hypotension occurs commonly during spinal anaesthesia for caesarean section with maternal and fetal adverse effects. The investigators developed a double-vasopressor automated system incorporating continuous non-invasive haemodynamic monitoring using NexfinTM with a two-step algorithm.

Detailed description

Hypotension occurs commonly during spinal anaesthesia for caesarean section with maternal and fetal adverse effects. We developed a double-vasopressor automated system incorporating continuous non-invasive haemodynamic monitoring using Nexfin cardiac output monitor with a two-step algorithm. The system delivered phenylephrine 25 mcg or ephedrine 2 mg (if heart rate\<60 beats.min-1) every 30 seconds when systolic blood pressure was between 90-100% of baseline. The system delivered phenylephrine 50 mcg or ephedrine 4 mg (if heart rate\<60 beats.min-1) every 30 seconds when systolic blood pressure was \<90% of baseline. A randomised controlled trial will be done to compare with manual bolus technique. With the manual bolus technique, phenylephrine 50mcg or ephedrine 4mg (if heart rate\<60 beats.min-1) every 60 seconds when systolic blood pressure was between 90-100% of baseline. The system delivered phenylephrine 100mcg or ephedrine 8mg (if heart rate\<60 beats.min-1) every 60 seconds when systolic blood pressure was \<90% of baseline.

Interventions

DEVICEvasopressor delivery automated system

vasopressor delivery using phenylephrine and ephedrine

DRUGphenylephrine
DRUGephedrine
DEVICEmanual vasopressor delivery

Sponsors

KK Women's and Children's Hospital
Lead SponsorOTHER_GOV

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
FEMALE
Age
21 Years to 45 Years
Healthy volunteers
No

Inclusion criteria

* age 21-45 years old, * weight 40-90 kg, * height 145-170 cm

Exclusion criteria

* contraindications to spinal anaesthesia, * allergy to drugs used in the study, and * those with uncontrolled medical conditions such as hypertension, diabetes mellitus, and cardiovascular disease

Design outcomes

Primary

MeasureTime frameDescription
Hypotension1 daySystolic blood pressure less than 80% of baseline systolic blood pressure

Secondary

MeasureTime frameDescription
Hypertension1 daySystolic blood pressure more than 120% of baseline systolic blood pressure
Nausea and vomiting1 dayNausea and vomiting during Caesarean section

Countries

Singapore

Contacts

PRINCIPAL_INVESTIGATORBan L Sng, FANZCA

KK Women's and Children's Hospital

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Aug 8, 2026